SML4126

Ginsenoside Rd

≥98% (HPLC)

• Synonyme(s) : (3β,12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside, 3-O-β-D-Glucopyranosyl-(1→2)-β-D-glucopyranosyl-20-O-β-D-glucopyranosyldammar-24-ene-3β,12β,20S-triol, Chikusetsusaponin FK7, Ginsenoside Rd1, Gypenoside VIII
• Formule empirique (notation de Hill) : C₄₈H₈₂O₁₈
• Numéro CAS: 52705-93-8
• Poids moléculaire : 947.15
• Code UNSPSC : 12352200

Propriétés

• Niveau de qualité: 100
• Essai: ≥98% (HPLC)
• Forme: powder
• Activité optique: [α]/D 17 to 23°, c = 0.5 in methanol
• Couleur: white to beige
• Solubilité: DMSO: 2 mg/mL, clear
• Température de stockage: -10 to -25°C

Description

Actions biochimiques/physiologiques

Triterpene saponin isolated from ginseng that demonstrates a range of pharmacological effects, such as anti-inflammatory, antioxidant, anti-cancer, neuroprotective, and cardiovascular protective properties.

Ginsenoside Rd, a potent triterpene saponin, derived from ginseng demonstrates a range of pharmacological effects, such as anti-inflammatory, antioxidant, anti-cancer, neuroprotective, and cardiovascular protective properties. Potential advantages include enhancing cognitive function, diminishing oxidative stress, and regulating the immune system. Ginsenoside-Rd acts on diverse signaling pathways, including the NF-κB pathway associated with inflammation. Moreover, Ginsenoside Rd is implicated in influencing neuronal function and shielding the brain from oxidative stress.